False-Positive Uptake of FDG in Hepatic Sarcoidosis
Authors:
- Andrew N. GuglielmiAGAndrew N. Guglielmi
- Benedict Y. KimBKBenedict Y. Kim
- Bohdan BybelBBBohdan Bybel
- Nancy SlifkinNSNancy Slifkin
- 1 March 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 31 (3) , 175
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- F-18 FDG Positron Emission Tomography and Benign FracturesClinical Nuclear Medicine, 2003
- Unsuspected Skeletal Sarcoidosis Mimicking Metastatic Disease on FDG Positron Emission Tomography and Bone ScintigraphyClinical Nuclear Medicine, 2003
- Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosisJournal of the Neurological Sciences, 2002
- Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findingsEuropean Radiology, 2002
- F-18 FDG–Positron Emission Tomographic Scanning and Wegener’s GranulomatosisClinical Nuclear Medicine, 2002
- FDG PET in the clinical evaluation of sarcoidosis with bone lesionsAnnals of Nuclear Medicine, 2000
- F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and InfectionClinical Nuclear Medicine, 2000
- Extrapulmonary Sarcoidosis Primarily Diagnosed in the LiverScandinavian Journal of Gastroenterology, 2000
- 'False-Positive' Uptake of FDG in a Hepatic AdenomaClinical Nuclear Medicine, 1997
- Sarcoidosis of the liver: Evaluation with multiple imaging modalitiesComputerized Medical Imaging and Graphics, 1992